+44 (0)20 8817 5296info@tritrials.com

Steven Law is our new SVP of Sales

Steven Law has been appointed as the new SVP of Sales for TRI. Steven is a global sales leader with over 32 years of management experience within the IT software and services industry in sales, marketing and business development roles both directly and through channel partners. Over the past 25 years Steven has been working with some of the…

Read More

Phil M’Caw new TRI CFO

Phil M’Caw has been appointed as the new Chief Financial Officer of TRI. Phil has over 25 years of hands-on experience of financial and commercial management in several sectors with growth businesses having international footprints. He trained as Chartered Accountant with KPMG London before moving into management consultancy with KPMG and then into roles in industry. He has worked…

Read More

Mike Lewis announced as Chair of TRI

Mike is Chair of 4 public and private healthcare companies and has 30 years global Health industry experience having previously held senior roles at Align Technology (Amsterdam), Boston Scientific (Paris), C.R. Bard (USA), Sybron (Switzerland) and Becton Dickinson (UK) and was President of Gambro (Sweden) leading the £3bn buyout. Having spent 22 of the last 25 years living and…

Read More

TRI raises multi-million growth funding

TRI raises multi-million growth funding from Octopus Investments to expand its Risk-Based Monitoring platform for clinical trials 15th October 2018, LONDON, UK – TRI, a leading global provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has completed a growth capital fundraise to accelerate development of its core technology platform, OPRA and expand its international presence. Founded in 2014,…

Read More

R2 survey results June 2018

Only 12% of companies reporting R2 readiness In June this year we conducted an industry survey on ICH E6 (R2) readiness, and had over 100 responses.  Only 12 % said they have completed their readiness programs.  Even more surprising, 27% of respondents said they haven’t even started yet. Given the adoption of R2 by EMA, FDA and Health Canada…

Read More

Webinar: OPRA – technology that makes quality management and R2 compliance simple

June 21, 10:00am EDT / 3:00pm BST Free webinar: OPRA – making quality management and R2 compliance simple       This webinar showcases TRI’s OPRA technology platform.  Learn how OPRA supports central monitoring, RBM, quality oversight and reporting. Understand what’s new in the latest release of OPRA and what’s upcoming in the next release.    To Register, click…

Read More

Webinar: A practical guide managing protocol risks

June 14, 10:00am EDT / 3:00pm BST Free Webinar: R2 readiness – A practical guide to protocol risk assessment, evaluation and implementing risk controls. This webinar is designed to help anyone planning to conduct protocol risk assessment and develop a quality management plan as part of ICH E6 (R2) compliance. The session will describe the regulatory context from ICH…

Read More

Webinar: What you need to know about R2

June 7, 10:00am EDT / 3:00pm BST Everything you need to know about the key ICH GCP E6 (R2) changes. It’s for anyone wanting know what R2 is, why it has been implemented and how it will impact your company. The impact of ICH E6 (R2) on any company running clinical trials is going to be significant. With most…

Read More

eLearning R2 Awareness Training

The fastest and most cost effective way to understand what ICH E6 (R2) is, why it is so important, and what it means to your organization. This 90-minute course is available as a self-serve eLearning package, or an instructor led webinar. The course is targeted at individuals within Sponsor organizations and CROs that are involved in the design, conduct…

Read More

Datatrial and TRI announce tech tie up

Datatrial and TRI announce tech tie up The clinical trials industry is going through the biggest regulatory change in two decades, forcing companies that run trials to adopt a data driven approach and focus more on quality risk management. Dr Emma Banks, CEO of Datatrial based in northeast England said: “We are delighted to announce Datatrial’s technology partnership with TRI. We…

Read More

TRI nominated for the 2016 Metrics Champion Consortium(MCC) Champion award

TRI has been selected as a member of this year’s group of MCC Champions – a special honor bestowed upon individuals who made significant contributions in 2016 to advancing the MCC mission to improve the efficiency, quality and effectiveness of clinical trials. As the Metrics Champion Consortium (MCC) passes its ten year anniversary, the original mission has stayed the…

Read More

EMA Announce Adoption Date for ICH E6 (R2)

As seen with ICH E6 (R1), the EMA have led the way, becoming the first to adopt. For convenience, we have added the adopted guidance document to our resources page: ICH E6 (R2) EMA Adopted Guidelines So, after a long year of discussion and delays in 2016, 2017 is going to be the year we really start to see…

Read More

Central Monitor Job Description

The role of the central monitor On the 17th November 2016, the ICH Assembly reported that they had adopted the important amendment, ICH E6 (R2) that aims to encourage sponsor to implement improved oversight and management of clinical trials and that the amendment would now be implemented by ICH members through national and regional guidance.   (http://www.ich.org/ichnews/press-releases/view/article/ich-assembly-osaka-japan-november-2016.html). While we wait…

Read More